Expression of vesicular monoamine transporters, synaptosomal-associated protein 25 and syntaxin1: A signature of human small cell lung carcinoma

Cancer Research

Volumn 61, Issue 5, 2001, Pages 2138-2144

  Graff, Lothar ^a   Castrop, Florian ^a   Bauer, Markus ^b   Höfler, Heinz ^b   Gratzl, Manfred ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOGENIC AMINE; CARRIER PROTEIN; N ETHYLMALEIMIDE; SECRETORY PROTEIN; SNARE PROTEIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER;

ADENOCARCINOMA; ARTICLE; CELL ORGANELLE; CONTROLLED STUDY; ENDOCRINE CELL; EXOCYTOSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG SMALL CELL CANCER; NORTHERN BLOTTING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

ADENOCARCINOMA; ANTIGENS, SURFACE; BLOTTING, NORTHERN; CARCINOMA, SMALL CELL; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NEUROPEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; SYNTAXIN 1; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; VESICULAR BIOGENIC AMINE TRANSPORT PROTEINS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 0035266294     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. The vesicular monoamine transporter: From chromaffin granule to brain
2. SNAP-25 is expressed in islets of Langerhans and is involved in insulin release
3. 2+- but not for GTPyS-induced insulin secretion
4. Release of vasopressin from isolated permeabilized neurosecretory nerve terminals is blocked by the light chain of botulinum A toxin
5. Exploring the functional domain and the target of the tetanus toxin light chain in neurohypophysial terminals
6. Protein kinase C and clostridial neurotoxins affect discrete and related steps in the secretory pathway
7. Synaptobrevin cleavage by the tetanus toxin light chain is linked to the inhibition of exocytosis in chromaffin cells
8. Distinct exocytotic responses of intact and permeabilised chromaffin cells after cleavage of the 25-kDa synaptosomal-associated protein (SNAP-25) or synaptobrevin by botulinum toxin A or B
9. Adrenal chromaffin cells contain functionally different SNAP-25 monomers and SNAP-25/syntaxin heterodimers
10. Functional importance of synaptobrevin and SNAP-25 during exocytosis of histamine by rat gastric enterochmmaffin-like cells
11. The mechanism of histamine secretion from gastric enterochromaffin-like cells
12. Mechanism of action of tetanus and botulinum neurotoxins
13. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin
14. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25
15. Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin
16. Tetanus toxin action: Inhibition of neurotransmitter release linked to synaptobrevin proteolysis
17. Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E
18. SNAP receptors implicated in vesicle targeting and fusion
19. A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion
20. Membrane fusion and exocytosis
21. Revised classification of neuroendocrine tumours of the lung, pancreas and gut
22. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking
23. Paraneoplastic syndromes
24. Serotonin (5-hydroxytryptamine) expression in pulmonary neuroendocrine cells (NE) and a netumor cell line
25. Aromatic L-amino acid decarboxylase activities in human lung tissues: Comparison between normal lung and lung carcinomas
26. Establishment, growth properties, and morphological characteristics of permanent human small cell lung cancer cell lines
27. Establishment and identification of small cell lung cancer cell lines having classic and variant features
28. NCAM: A surface marker for human small cell lung cancer cells
29. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter
30. The syntaxin family of vesicular transport receptors
31. The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations
32. Assembly and disassembly of a ternary complex of synaptobrevin, syntaxin, and SNAP-25 in the membrane of synaptic vesicles
33. Immunohistochemical study of small cell lung carcinoma; with special reference to the neuroendocrine markers aromatic L-amino acid decarboxylase and gastrin-releasing peptide
34. Expression of synaptotagmin and syntaxin associated with N-type calcium channels in small cell lung cancer
35. Molekule der regulierten sekretion sind differenzierungsmarker neuroendokriner tumoren
36. Immunohistochemical, ultrastructural and molecular study of well differentiated adenocarcinomas of the lung predominantly composed of goblet cells
37. Peripheral pulmonary adenocarcinomas with bronchioloalveolar features: Immunophenotypes correlate with histologic patterns
38. Expression of the embryonal neural cell adhesion molecule N-CAM in lung carcinoma. Diagnostic usefulness of monoclonal antibody 735 for the distinction between small cell lung cancer and non-small cell lung cancer
39. Immunocytochemical analysis of the synaptic proteins SNAP-25 and Rab3A in human pituitary adenomas. Overexpression of SNAP-25 in the mammmosomatotroph lineages
40. A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter
41. Expression cloning of a reserpine-sensitive vesicular monoamine transporter
42. Functional identification and molecular cloning of a human brain vesicle monoamine transporter
43. Expression of vesicular monoamine transporters in endocrine hyperplasia and endocrine tumors of the oxyntic stomach
44. Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumors
45. Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells
46. Pheochromocytomas: Imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET
47. Decreased striatal monoaminergic terminals in severe chronic alcoholism demonstrated with (+)[11C]dihydrotetrabenazine and positron emission tomography
48. Decreased striatal monoaminergic terminals in multiple system atrophy detected with positron emission tomography